Literature DB >> 8568229

Anergy as a mechanism of peripheral T cell tolerance.

H Quill1.   

Abstract

Mesh：

Substances：

Year:  1996        PMID： 8568229

Source DB:  PubMed          Journal:  J Immunol        ISSN： 0022-1767            Impact factor:   5.422


× No keyword cloud information.
  8 in total

1.  A logical analysis of T cell activation and anergy.

Authors:  M Kaufman; F Andris; O Leo
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-30       Impact factor: 11.205

Review 2.  Science, medicine, and the future: Tolerance and autoimmunity.

Authors:  I R Mackay
Journal:  BMJ       Date:  2000-07-08

3.  Peyer's patches are required for oral tolerance to proteins.

Authors:  K Fujihashi; T Dohi; P D Rennert; M Yamamoto; T Koga; H Kiyono; J R McGhee
Journal:  Proc Natl Acad Sci U S A       Date:  2001-03-13       Impact factor: 11.205

4.  Intravenous tolerization with type II collagen induces interleukin-4-and interleukin-10-producing CD4+ T cells.

Authors:  M L Gumanovskaya; L K Myers; E F Rosloniec; J M Stuart; A H Kang
Journal:  Immunology       Date:  1999-07       Impact factor: 7.397

Review 5.  The interplay of T cell responses to viral and autoimmune epitopes.

Authors:  E Heber-Katz
Journal:  Immunol Res       Date:  1998       Impact factor: 2.829

Review 6.  Mechanisms of peripheral immune tolerance: conversion of the immune to the unresponsive phenotype.

Authors:  Sandra J Saouaf; Patrick J Brennan; Yuan Shen; Mark I Greene
Journal:  Immunol Res       Date:  2003       Impact factor: 2.829

Review 7.  Autoimmunity. Thoughts for the millennium.

Authors:  I R Mackay; J Van de Water; M E Gershwin
Journal:  Clin Rev Allergy Immunol       Date:  2000-02       Impact factor: 10.817

8.  Short-term administrations of a combination of anti-LFA-1 and anti-CD154 monoclonal antibodies induce tolerance to neonatal porcine islet xenografts in mice.

Authors:  Hossein Arefanian; Eric B Tredget; Ray V Rajotte; Ron G Gill; Gregory S Korbutt; Gina R Rayat
Journal:  Diabetes       Date:  2010-01-19       Impact factor: 9.461
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.